Compare LEGN & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | NOV |
|---|---|---|
| Founded | 2014 | 1862 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.7B |
| IPO Year | 2020 | 1996 |
| Metric | LEGN | NOV |
|---|---|---|
| Price | $22.14 | $17.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | ★ $69.33 | $16.71 |
| AVG Volume (30 Days) | 2.1M | ★ 3.9M |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | $909,045,000.00 | ★ $8,775,000,000.00 |
| Revenue This Year | $68.20 | N/A |
| Revenue Next Year | $47.77 | N/A |
| P/E Ratio | ★ N/A | $18.06 |
| Revenue Growth | ★ 74.75 | N/A |
| 52 Week Low | $20.21 | $10.84 |
| 52 Week High | $45.30 | $18.22 |
| Indicator | LEGN | NOV |
|---|---|---|
| Relative Strength Index (RSI) | 42.47 | 66.43 |
| Support Level | $20.21 | $17.55 |
| Resistance Level | $24.12 | $18.22 |
| Average True Range (ATR) | 1.05 | 0.55 |
| MACD | 0.30 | 0.13 |
| Stochastic Oscillator | 47.57 | 89.87 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.